This ASX biotech share just posted 144% half year revenue growth

Shares in ASX biotech provider Zoono Group Ltd (ASX: ZNO) could move in early trade today after the group posted its half year results and an update on its current quarter.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Zoono Group Ltd (ASX: ZNO) share price will be on watch when trade opens on the ASX this morning, following the release of its half year earnings for the period ended 31 December 2019 after market close yesterday.

In a separate market release, the global biotech provider also updated the market on its current quarter.

a woman

What did Zoono announce for H1 FY20?

The group reported revenue from ordinary activities of NZ$1,714,980, an increase of 144% on the prior corresponding period (pcp). Zoono recorded an after-tax loss of NZ$727,944, compared to an after-tax loss of NZ$1,377,645 in H1 FY19.

Zoono achieved a gross profit of NZ$893,443, which was 52.1% of operating revenue. The group attributes the improved gross profit to higher operating revenues and margins from bulk products sales, compared to the sale of finished product sales.

Operating costs also decreased by NZ$335,184 as a result of a review of all costs across the group.

No final dividend was paid or declared in relation to the year ended 30 June 2019 and no interim dividend will be paid or declared in relation to the half-year ended 31 December 2019.

In terms of operations, Zoono reports that its global offline and online sales continue to increase as brand awareness grows and its new distribution strategy starts to produce results. The group also signed a number of new distributor agreements in the half year in the agriculture, childcare and hotel sectors in China and Vietnam. It also signed an agreement with Apiam Animal Health Ltd (ASX: AHX) (via Zoono Poultry) in Australia and in the United States.

Results for the current quarter

In a separate market release yesterday, Zoono announced revenues (unaudited) for the current quarter (7 weeks only) of NZ$3.5 million, which compares to revenues of NZ$1.715 million for the whole of the first half of FY20.

The company reported that its available cash resources had increased to over NZ$4 million, up more than NZ$1 million since 31 December 2019. Zoono further commented that online sales are now averaging NZ$30,000 to NZ$50,000 per day and the percentage gross margin on sales is also increasing in line with the growth in sales revenues.

Zoono also noted that work is progressing on a number of significant distribution and supply initiatives. Details of these initiatives will be announced to the market once negotiations are concluded.

To keep ahead of the high demand for its products, Zoono is ramping up production and relocating to a substantially larger warehouses and office facilities in early March 2020.

Motley Fool contributor Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

3 children standing on podiums wearing Olympic medals.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a lacklustre end to the trading week this Friday...

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Broker Notes

2 ASX 200 stocks that could rise 50%

Morgans thinks the market is undervaluing these shares.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Technology Shares

I was going to buy these ASX tech stocks. Now, I'm not so sure

When the facts change, so should our buying...

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Dollar sign in yellow with a red falling arrow in front of a graph, symbolising a falling share price.
Broker Notes

6 ASX 200 shares downgraded by brokers this week

Brokers have reduced their ratings on TechnologyOne, Macquarie, 4DMedical, and others this week.

Read more »

three young children weariing business suits, helmets and old fashioned aviator goggles wear aeroplane wings on their backs and jump with one arm outstretched into the air in an arid, sandy landscape.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors sent these three ASX 200 stocks surging in this week’s tumbling market. But why?

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why Brainchip, Fortescue, IGO, and Life360 shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

Five happy friends on their phones.
Share Market News

Why Newmont, PLS and Fortescue shares are grabbing headlines on Friday

Fortescue, PLS and Newmont shares are grabbing investor interest on Friday. But why?

Read more »